COMP <GO>
RLAY vs IOVA // NET PROFIT MARGIN
Relay Therapeutics Inc. (NASDAQ) VS. Iovance Biotherapeutics Inc. (NASDAQ) • 15-METRIC TALLY: RLAY 3
— IOVA 1
■ METRIC PARITY
LAST: $17.28 (-5.83%) • MKT CAP: $3.79B
net-margins
-60.00%
LAST: $8.02 (-5.42%) • MKT CAP: $3.63B
net-margins
-60.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RLAY VS. IOVA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RLAY | IOVA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 34.30% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -5.53% | -7.76% | +2.23 | RLAY | /fcf-yield <GO> |
| Operating Margin | -60.00% | -60.00% | 0.00 | TIE | /operating-margins <GO> |
| Net Profit Margin ACTIVE | -60.00% | -60.00% | 0.00 | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 53.40% | 60.60% | -7.20 | IOVA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 7.08 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 4/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 43.5 | 31.8 | +11.70 | RLAY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.99 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 33.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.79B | $3.63B | $153.9M | RLAY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RLAY REV | IOVA REV | RLAY GROSS % | IOVA GROSS % | RLAY FCF | IOVA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $15.4M | $263.5M | — | 34.3% | -$235.9M | -$336.2M |
| FY 2024 | $10.0M | $164.1M | — | 43.2% | -$251.1M | -$364.0M |
| FY 2023 | $25.5M | $1.2M | — | — | -$300.3M | -$361.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RLAY // BETA —
IOVA // BETA 0.99